Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm.
暂无分享,去创建一个
[1] Ronald A. DePinho,et al. Model organisms: The mighty mouse: genetically engineered mouse models in cancer drug development , 2006, Nature Reviews Drug Discovery.
[2] M E Phelps,et al. Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Ziegler,et al. Instrumentation and Data Acquisition , 2006 .
[4] Sanjiv S Gambhir,et al. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. , 2005, Analytical chemistry.
[5] Adi F. Gazdar,et al. Translational research comes of age , 1996, Nature Medicine.
[6] Sanjiv S. Gambhir,et al. How molecular imaging is speeding up antiangiogenic drug development , 2006, Molecular Cancer Therapeutics.
[7] A. Signore,et al. Receptor targeting agents for imaging inflammation/infection: where are we now? , 2006, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.
[8] R. Peters. Nanoscopic medicine: the next frontier. , 2006, Small.
[9] R. Blasberg. Molecular imaging and cancer. , 2003, Molecular cancer therapeutics.
[10] W. Richter. Imaging biomarkers as surrogate endpoints for drug development , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[11] A. Papavassiliou. Biochemistry versus molecular medicine: what should we be teaching our medical students? , 1999, Molecular medicine today.
[12] S. Gambhir,et al. Imaging Gene Expression: Concepts and Future Outlook , 2006 .
[13] M. Sandler. Diagnostic Nuclear Medicine , 2002 .
[14] M. Mann,et al. Proteomics to study genes and genomes , 2000, Nature.
[15] E. Petricoin,et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery , 2006, Nature Reviews Cancer.
[16] K. Birmingham. What is translational research? , 2002, Nature Medicine.
[17] J M Hoffman,et al. Molecular imaging in cancer: future directions and goals of the National Cancer Institute. , 2000, Academic radiology.
[18] U. Bhalla,et al. Complexity in biological signaling systems. , 1999, Science.
[19] Daniel C Sullivan,et al. Challenges and Opportunities for In Vivo Imaging in Oncology , 2002, Technology in cancer research & treatment.
[20] Gregory S Karczmar,et al. MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.
[21] Mingjun Zhang,et al. Bio-Microarray Fabrication Techniques—A Review , 2006, Critical reviews in biotechnology.
[22] Paul Workman,et al. Translating basic cancer research into new cancer therapeutics. , 2002, Trends in molecular medicine.
[23] S. Larson,et al. The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development , 2005, Clinical Cancer Research.
[24] L. Pauling,et al. Sickle cell anemia a molecular disease. , 1949, Science.
[25] Valentina Svicher,et al. Novel drug resistance mutations in HIV: recognition and clinical relevance. , 2006, AIDS reviews.
[26] M. Gassmann,et al. From Genetically Altered Mice to Integrative Physiology. , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[27] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[28] C. Seidman,et al. Molecular medicine in the 21st century , 2001, Internal medicine journal.
[29] Jürg Zimmermann,et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.
[30] J. Pober,et al. Obstacles facing translational research in academic medical centers , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] U. Alon. Biological Networks: The Tinkerer as an Engineer , 2003, Science.
[32] G. Tucker,et al. Clinical Measurement in Drug Evaluation , 1991 .
[33] Robert J Gillies,et al. I2 imaging: cancer biology and the tumor microenvironment. , 2006, Cancer research.
[34] D. Piwnica-Worms,et al. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. , 2005, Cancer cell.
[35] N. Tamaki,et al. Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[36] Ralph Weissleder,et al. Molecular imaging in the clinical arena. , 2005, JAMA.
[37] D. Ganten,et al. Transgenic animals as models for human disease. , 1995, Clinical and experimental hypertension.
[38] Juewen Liu,et al. Functional DNA nanotechnology: emerging applications of DNAzymes and aptamers. , 2006, Current opinion in biotechnology.
[39] K Wienhard,et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas , 2001, The Lancet.
[40] Michael E Phelps,et al. Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.
[41] S. Huang,et al. Dimensions of systems biology. , 2006, Reviews of physiology, biochemistry and pharmacology.
[42] David A. Benaron,et al. The Future of Cancer Imaging , 2004, Cancer and Metastasis Reviews.
[43] C. Sigman,et al. New science-based endpoints to accelerate oncology drug development. , 2005, European journal of cancer.
[44] M. Kassiou,et al. Imaging sigma receptors: applications in drug development. , 2007, Current pharmaceutical design.
[45] G. Chiro. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .
[46] S. Iyengar. The quest for genes causing complex traits in ocular medicine: successes, interpretations, and challenges. , 2007, Archives of ophthalmology.
[47] I. Tannock,et al. The translational research chain: is it delivering the goods? , 2001, International journal of radiation oncology, biology, physics.
[48] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[49] Sanjiv S Gambhir,et al. Reporter gene imaging of protein-protein interactions in living subjects. , 2007, Current opinion in biotechnology.
[50] T. O'Dorisio,et al. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. , 2002, Seminars in nuclear medicine.
[51] S. Libutti,et al. Molecular imaging of tumor angiogenesis , 2002, Journal of cellular biochemistry. Supplement.
[52] A. Papavassiliou. Clinical practice in the new era , 2001, EMBO reports.
[53] Jonathon Bishop,et al. Magnetic resonance imaging for detection and analysis of mouse phenotypes , 2005, NMR in biomedicine.
[54] King Li,et al. Combined vascular targeted imaging and therapy: A paradigm for personalized treatment , 2002, Journal of cellular biochemistry. Supplement.
[55] D. Weatherall. Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000 , 2001, British journal of haematology.
[56] E. Ritchie,et al. Mechanisms of resistance to imatinib in CML patients: a paradigm for the advantages and pitfalls of molecularly targeted therapy. , 2006, Current cancer drug targets.
[57] S. Gambhir. Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.
[58] P. Price,et al. Molecular imaging: what picture does it paint for future oncology? , 2002, Drug discovery today.
[59] R. Salgia,et al. Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer , 2006, Respirology.
[60] W. Eckelman,et al. Imaging of muscarinic receptors in the central nervous system. , 2006, Current pharmaceutical design.
[61] J. Barrio,et al. Assays for noninvasive imaging of reporter gene expression. , 1999, Nuclear medicine and biology.
[62] E. Holland,et al. Bioluminescence technology for imaging cell proliferation. , 2005, Current opinion in biotechnology.
[63] E. Winzeler,et al. Genomics, gene expression and DNA arrays , 2000, Nature.
[64] R. S. Williams,et al. Transgenic animals in integrative biology: approaches and interpretations of outcome. , 2000, Journal of applied physiology.
[65] R. Blasberg,et al. Reporter gene imaging: potential impact on therapy. , 2005, Nuclear medicine and biology.
[66] Ronald G Blasberg,et al. In vivo molecular‐genetic imaging , 2002, Journal of cellular biochemistry. Supplement.
[67] D C Wight,et al. Transgenic mice: a decade of progress in technology and research. , 1994, Mutation research.
[68] Patrick S Daugherty,et al. Microfluidic protein detection through genetically engineered bacterial cells. , 2006, Journal of proteome research.
[69] M G Pomper,et al. Molecular imaging: an overview. , 2001, Academic radiology.
[70] D. Piwnica-Worms,et al. Molecular imaging strategies for drug discovery and development. , 2006, Current opinion in chemical biology.